Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Incidence of biosimilars on the total marketed products in Italy in 2018, by molecule

Incidence of biosimilar drugs on the total marketed products in 2018, by molecule

by Statista Research Department, last edited Aug 21, 2019
Incidence of biosimilars on the total marketed products in Italy in 2018, by molecule The graph displays the incidence of biosimilar drugs on the total marketed products in Italy in 2018, by molecule. According to data, Filgrastim, Epoetin and Infliximab were the molecules for which the incidence of biosimilar variations on the total marketed products was higher. More specifically, the biosimilar drugs produced from Filgrastim accounted for 95.14 percent of the total sales of this molecule, while all the other products represented 4.86 percent of the market.
Show more

Incidence of biosimilar drugs on the total marketed products in 2018, by molecule

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Related Studies: Available to Download in PDF or PPTX Format
Generics and biosimilars in Italy
Generics and biosimilars in Italy

All Information
in one Presentation

Generics and biosimilars in Italy

Everything On "Generics and biosimilars in Italy" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield

Marlene Greenfield
Vice President, Hearst Magazines

Statistics on "Generics and biosimilars in Italy"
  • Global overview
  • Italy: pharmaceutical market and industry
  • Biosimilar drugs
The most important statistics
  • Generic drugs
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.